FDA Approves Pfizer Booster Shots for Kids Aged 12-15
MONDAY, Jan. 3, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer’s booster shot against COVID-19 for youths aged 12 to 15. The move comes as the Omicron variant spreads across the country and students return to classrooms following the holidayContinue Reading